$0.6664
-0.02-2.98%
At close: -
$0.6797
0.012.00%
After Hours: 5:00 PM EDT
Comments
Loading...
Karyopharm Therapeutics (NASDAQ:KPTI) Stock, Earnings Estimates, EPS, And Revenue
Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 27
EPS Estimate
$-0.250
Quarterly Revenue Estimate
$37.74M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$148.44M
Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Karyopharm Therapeutics (KPTI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-05 | $-0.26 | $-0.26 | 0.00 % |
| Q2 | 2024-08-06 | $-0.20 | $-0.30 | 33.3 % |
| Q1 | 2024-05-08 | $-0.32 | $-0.33 | 3.03 % |
| Q4 | 2024-02-29 | $-0.36 | $-0.31 | -16.1 % |
Karyopharm Therapeutics (KPTI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-05 | $38.78M | $37.79M | 2.63 % |
| Q2 | 2024-08-06 | $42.79M | $36.18M | 18.3 % |
| Q1 | 2024-05-08 | $33.13M | $34.47M | -3.90 % |
| Q4 | 2024-02-29 | $33.75M | $35.40M | -4.67 % |
FAQ
When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?
Karyopharm Therapeutics (KPTI) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?
The Actual EPS was $-0.26, which hit the estimate of $-0.26.
What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?
The Actual Revenue was $38.8M, which beat the estimate of $37.8M.
Browse earnings estimates, EPS, and revenue on all stocks.